# A Phase I Study of iPS Cell Generation From Patients With COPD

> **NCT01860898** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 31 (actual)

## Conditions studied

- Thoracic Diseases
- Respiratory Tract Diseases
- Cancer of Lung
- Cancer of the Lung
- Lung Cancer
- Lung Diseases, Obstructive
- COPD
- Pulmonary Emphysema
- Neoplasms, Lung
- Neoplasms, Pulmonary
- Pulmonary Cancer
- Pulmonary Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Small Cell

## Interventions

- **OTHER:** Skin Biopsy

## Key facts

- **NCT ID:** NCT01860898
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2014-10-28
- **Final completion:** 2014-10-28
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01860898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01860898, "A Phase I Study of iPS Cell Generation From Patients With COPD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01860898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*